Paradigm-shifting platforms I, IO: Taking IO to the next Level

Tuesday, May 5, 2020 | 9:00 – 10:15 am


  • Jeffrey M. Bockman, PhD, EVP, Oncology Practice Head, Cello Health BioConsulting


  • Jacob Becraft, PhD, CEO, Co-founder, Strand Therapeutics
  • Frank Borriello, MD, PhD, Founder & CEO, Alloplex Biotherapeutics Inc.
  • Mary Haak-Frendscho, PhD, President & CEO, Spotlight Therapeutics
  • Laurent Levy, PhD, CEO Nanobiotix
  • Ulrik Nielsen, CEO, Tidal Therapeutics
  • Lini Pandite, MD, CMO, Shattuck Labs, Inc.
  • Sijme Zeilemaker, COO, Immunicum